ASCO 2018: Sipuleucel-T OS and Clinical Outcomes by Baseline PSA Quartiles in Patients with ...

… Pharmaceuticals, LLC, Seattle, WA; Dendreon Pharmaceuticals LLC, Seattle, WA, US; Duke Cancer Institute, Duke University, Durham, NC
…read more

Read more here:: ASCO 2018: Sipuleucel-T OS and Clinical Outcomes by Baseline PSA Quartiles in Patients with …